Could ADVANTIS CORPORATION (OTCMKTS:ADVT) See a Reversal After More Sellers Came In?

June 17, 2018 - By Linda Rogers

Advantis Corp. (OTCMKTS:ADVT) Logo

The stock of ADVANTIS CORPORATION (OTCMKTS:ADVT) registered an increase of 460% in short interest. ADVT’s total short interest was 8,400 shares in June as published by FINRA. Its up 460% from 1,500 shares, reported previously.

The stock decreased 2.30% or $0.001 during the last trading session, reaching $0.034. About 837,611 shares traded. Advantis Corp. (OTCMKTS:ADVT) has 0.00% since June 17, 2017 and is . It has underperformed by 12.57% the S&P500.

Advantis Corp. develops and markets products focusing on medical cannabis, research, and pharmaceutical sectors. The company has market cap of $33.27 million. The firm offers pain management and healthcare solutions. It currently has negative earnings. Advantis Corp. was formerly known as Ramoil Management, Ltd. and changed its name to Advantis Corp. in December 2015.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.